In a wrapup of some recent activity at TNInvestco funds, Milt Capps writes about TriStar's Technology's interest in a young San Francisco-area company that's developing technology to better analyze molecular interaction and thus help speed up drug development projects. The company's approach is based concepts that originated at Vanderbilt University and its acceptance of TriStar's cash should lead it to relocate its home office here.